Home > Name List By other > (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Japan

CAS No 58-61-7 , (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Search by region : Japan

  • Name: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
  • Synonyms: Myocol; Boniton;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol; Adenine riboside; Adenoscan;Adenocard; Adenocor; Adenine nucleoside; Nucleocardyl; Sandesin;
  • CAS Registry Number:
  • Transport: OTH
  • Melting Point: 234-236 ºC
  • Density: 2.08 g/cm3
  • Refractive index: 1.907
  • Water Solubility: soluble (soluble in caustic soda)
  • Safety Statements: S24/25;
  • Hazard Symbols: Not regulated UN NO.
  • EINECS: 200-389-9
  • Molecular Weight: 267.24132
  • InchiKey: OIRDTQYFTABQOQ-KQYNXXCUSA-N
  • InChI: InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)
    19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
  • Risk Statements: S24/25:Avoidcontactwithskinandeyes.;
  • Molecular Formula: C10H13N5O4
  • Molecular Structure:CAS No:58-61-7 (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

Select to

58-61-7 Adenosine

  • Adenosine
  • Japan Chemiplus Corporation [Manufacturer]
  • Tel: +81 3 3440 9015
  • Fax: +81 3 3440 9016
  • Address: Suite 514 AIOS Gotanda 1-10-7 Higashi-gotanda, Shinagawa-ku 141-0022 TokyoJAPAN Tokyo,Japan
Contact Supplier

Select to

References of (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Title: Adenosine
CAS Registry Number: 58-61-7
CAS Name: 9-b-D-Ribofuranosyl-9H-purin-6-amine
Synonyms: 6-amino-9-b-D-ribofuranosyl-9H-purine; 9-b-D-ribofuranosidoadenine; adenine riboside
Trademarks: Adenocard (Fujisawa); Adenocor (Sanofi Winthrop); Adenoscan (Fujisawa)
Molecular Formula: C10H13N5O4
Molecular Weight: 267.24
Percent Composition: C 44.94%, H 4.90%, N 26.21%, O 23.95%
Literature References: Nucleoside; widely distributed in nature. From yeast nucleic acid: Levene and Bass, Nucleic Acids (New York, 1931) p 163. Structure: Levene, Tipson, J. Biol. Chem. 94, 809 (1932); Bredereck, Ber. 66, 198 (1933); Z. Physiol. Chem. 223, 61 (1934); Gulland, Holiday, J. Chem. Soc. 1936, 765. Cf. Szent-Gy?rgyi, J. Physiol. 68, 213 (1930); Lythgoe et al., J. Chem. Soc. 1947, 355; 1948, 965. Synthesis: Davoll et al., ibid. 1948, 967; H. Vorbrueggen, K. Krolikiewicz, Angew. Chem. Int. Ed. 14, 421 (1975). Crystal structure: T. F. Lai, R. E. Marsh, Acta Crystallogr. B28, 1982 (1972). Conformational properties: D. B. Davies, A. Rabczenko, J. Chem. Soc. Perkin Trans. 2 1975, 1703. Symposium on cardiac electrophysiology, pharmacology and clinical efficacy in supraventricular tachycardia: Prog. Clin. Biol. Res. 230, 1-395 (1987). Reviews: see Adenine.
Properties: Crystals from water, mp 234-235°. [a]D11 -61.7° (c = 0.706 in water); [a]9D -58.2° (c = 0.658 in water). uv max: 260 nm (e 15100). Practically insol in alcohol.
Melting point: mp 234-235°
Optical Rotation: [a]D11 -61.7° (c = 0.706 in water); [a]9D -58.2° (c = 0.658 in water)
Absorption maximum: uv max: 260 nm (e 15100)
Therap-Cat: Antiarrhythmic.
Keywords: Antiarrhythmic.